HIGHLIGHTS
- who: Na+/K+-ATPase and collaborators from the Key Laboratory of Protein and Peptide Pharmaceuticals, CAS-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China have published the research: Protein Cell 5(7):532-543, in the Journal: (JOURNAL) of October/31,/1988
- what: The authors demonstrate that is up-regulated in hepatocellular carcinoma (HCC) and enhances the migration and proliferation of HCC cells. The authors show that blocking FXYD6 with its mAb inhibits liver tumor growth. With this powerful tool, the authors provide the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.